10-Q – Page 117 – China Stock Advice

EVK [Ever-Glory International,] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended September 30, 2013 o For the transition period from ____________ to ____________ Ever-Glory International Group Inc. Florida 65-0420146 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, People’s Republic of China (8625) 5209-6875 x o x o] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 4 f10q0913ex32i_evergloryinter.htm CERTIFICATION] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jiansong Wang Chief Finance Officer (Principal Financial Officer) EX-32.2 5 f10q0913ex32ii_evergloryinte.htm CERTIFICATION]

By info| 2016-03-02T14:59:57+00:00 November 14th, 2013|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q, 2013-11-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2013

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By info| 2016-03-03T10:38:35+00:00 November 14th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2013-11-14, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By info| 2016-03-01T03:53:33+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2013-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By info| 2016-03-01T03:54:36+00:00 November 14th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-Q, 2013-11-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

NFEC [NF Energyvingrp] 10-Q: (Original Filing)

[FORM 10-Q x September 30 , 2013 NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Room 3106 Block C, 390 Qingnian Avenue, Heping District Shenyang, P. R. China 110002 (8624) 2560-9775 x o x o o o Large accelerated filer o] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Lihua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Gang Li ( v360177_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Lihua, Wang Principal Financial and Accounting Officer) ( v360177_ex32-2.htm]

By info| 2016-02-08T06:51:22+00:00 November 14th, 2013|Categories: Chinese Stocks, NFEC, SEC Original|Tags: 0001213660, 10-Q, 2013-11-14, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

NFEC [NF Energyvingrp] 10-Q: FORM 10-Q x September 30 , 2013 NF

[FORM 10-Q x September 30 , 2013 NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) Room 3106 Block C, 390 Qingnian Avenue, Heping District Shenyang, P. R. China 110002 (8624) 2560-9775 x o x o o o Large accelerated filer o] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Lihua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Gang Li ( v360177_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended September 30, 2013. NF Energyvingrporation Lihua, Wang Principal Financial and Accounting Officer) ( v360177_ex32-2.htm]

By info| 2016-02-08T06:52:23+00:00 November 14th, 2013|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: 0001213660, 10-Q, 2013-11-14, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86- 898-6681-1730 (China)] [CERTIFICATION OF OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321093013.htm]

By info| 2016-02-07T21:28:39+00:00 November 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2013

[FORM 10-Q (Mark One) x September 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Nevada 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86- 898-6681-1730 (China)] [CERTIFICATION OF OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THERBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) cphi10qex321093013.htm]

By info| 2016-02-07T21:29:09+00:00 November 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-11-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[FORM 10-Q September 30, 2013 For the quarterly period ended or For the transition period from ______ to______ 001-52186 KANDI TECHNOLOGIES GROUP, INC. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Jinhua City Industrial Zone Jinhua, Zhejiang Province Peoples Republic of China Post Code 321016 ___________ (86 - 579) 82239856 Large accelerated filer [] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 1]

By info| 2016-03-18T12:52:18+00:00 November 14th, 2013|Categories: Chinese Stocks, KNDI, SEC Original|Tags: 0001316517, 10-Q, 2013-11-14, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)

[FORM 10-Q þ September 30, 2013 For the quarterly period ended or o For the transition period from 001-34711 CHINA JO-JO DRUGSTORES, INC. Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86 (571) 88077078 N/A] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer EX-32.1 4 f10q0913ex32i_chinajojo.htm CERTIFICATION] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0913ex32ii_chinajojo.htm CERTIFICATION]

By info| 2016-03-11T04:17:57+00:00 November 14th, 2013|Categories: Chinese Stocks, CJJD, SEC Original|Tags: 0001413263, 10-Q, 2013-11-14, 2833, CJJD, MEDICINAL CHEMICALS and BOTANICAL PRODUCTS|0 Comments